Global Certolizumab Pegol Market Growth (Status and Outlook) 2023-2029

March 2023 | 63 pages | ID: G5F054BC02EEN
LP Information

Abstracts

The report requires updating with new data and is sent in 48 hours after order is placed.

Certolizumab pegol (CDP870, tradename Cimzia) is a biologic medication for the treatment of Crohn's disease, rheumatoid arthritis, psoriatic arthritis and ankylosing spondylitis.

LPI (LP Information)' newest research report, the “Certolizumab Pegol Industry Forecast” looks at past sales and reviews total world Certolizumab Pegol sales in 2022, providing a comprehensive analysis by region and market sector of projected Certolizumab Pegol sales for 2023 through 2029. With Certolizumab Pegol sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Certolizumab Pegol industry.

This Insight Report provides a comprehensive analysis of the global Certolizumab Pegol landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Certolizumab Pegol portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Certolizumab Pegol market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Certolizumab Pegol and breaks down the forecast by type, by application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Certolizumab Pegol.

The global Certolizumab Pegol market size is projected to grow from US$ million in 2022 to US$ million in 2029; it is expected to grow at a CAGR of % from 2023 to 2029.

United States market for Certolizumab Pegol is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

China market for Certolizumab Pegol is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Europe market for Certolizumab Pegol is estimated to increase from US$ million in 2022 to US$ million by 2029, at a CAGR of % from 2023 through 2029.

Global key Certolizumab Pegol players cover UCB. etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2022.

This report presents a comprehensive overview, market shares, and growth opportunities of Certolizumab Pegol market by product type, application, key players and key regions and countries.

Market Segmentation:

Segmentation by type

• Single-dose vial
• Single-dose prefilled syringe

Segmentation by application

• Crohn’s disease
• Active rheumatoid arthritis
• Active psoriatic arthritis

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• UCB

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Certolizumab Pegol Market Size 2018-2029
  2.1.2 Certolizumab Pegol Market Size CAGR by Region 2018 VS 2022 VS 2029
2.2 Certolizumab Pegol Segment by Type
  2.2.1 Single-dose vial
  2.2.2 Single-dose prefilled syringe
2.3 Certolizumab Pegol Market Size by Type
  2.3.1 Certolizumab Pegol Market Size CAGR by Type (2018 VS 2022 VS 2029)
  2.3.2 Global Certolizumab Pegol Market Size Market Share by Type (2018-2023)
2.4 Certolizumab Pegol Segment by Application
  2.4.1 Crohn’s disease
  2.4.2 Active rheumatoid arthritis
  2.4.3 Active psoriatic arthritis
2.5 Certolizumab Pegol Market Size by Application
  2.5.1 Certolizumab Pegol Market Size CAGR by Application (2018 VS 2022 VS 2029)
  2.5.2 Global Certolizumab Pegol Market Size Market Share by Application (2018-2023)

3 CERTOLIZUMAB PEGOL MARKET SIZE BY PLAYER

3.1 Certolizumab Pegol Market Size Market Share by Players
  3.1.1 Global Certolizumab Pegol Revenue by Players (2018-2023)
  3.1.2 Global Certolizumab Pegol Revenue Market Share by Players (2018-2023)
3.2 Global Certolizumab Pegol Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 CERTOLIZUMAB PEGOL BY REGIONS

4.1 Certolizumab Pegol Market Size by Regions (2018-2023)
4.2 Americas Certolizumab Pegol Market Size Growth (2018-2023)
4.3 APAC Certolizumab Pegol Market Size Growth (2018-2023)
4.4 Europe Certolizumab Pegol Market Size Growth (2018-2023)
4.5 Middle East & Africa Certolizumab Pegol Market Size Growth (2018-2023)

5 AMERICAS

5.1 Americas Certolizumab Pegol Market Size by Country (2018-2023)
5.2 Americas Certolizumab Pegol Market Size by Type (2018-2023)
5.3 Americas Certolizumab Pegol Market Size by Application (2018-2023)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Certolizumab Pegol Market Size by Region (2018-2023)
6.2 APAC Certolizumab Pegol Market Size by Type (2018-2023)
6.3 APAC Certolizumab Pegol Market Size by Application (2018-2023)
6.4 China
6.5 Japan
6.6 Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Certolizumab Pegol by Country (2018-2023)
7.2 Europe Certolizumab Pegol Market Size by Type (2018-2023)
7.3 Europe Certolizumab Pegol Market Size by Application (2018-2023)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Certolizumab Pegol by Region (2018-2023)
8.2 Middle East & Africa Certolizumab Pegol Market Size by Type (2018-2023)
8.3 Middle East & Africa Certolizumab Pegol Market Size by Application (2018-2023)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL CERTOLIZUMAB PEGOL MARKET FORECAST

10.1 Global Certolizumab Pegol Forecast by Regions (2024-2029)
  10.1.1 Global Certolizumab Pegol Forecast by Regions (2024-2029)
  10.1.2 Americas Certolizumab Pegol Forecast
  10.1.3 APAC Certolizumab Pegol Forecast
  10.1.4 Europe Certolizumab Pegol Forecast
  10.1.5 Middle East & Africa Certolizumab Pegol Forecast
10.2 Americas Certolizumab Pegol Forecast by Country (2024-2029)
  10.2.1 United States Certolizumab Pegol Market Forecast
  10.2.2 Canada Certolizumab Pegol Market Forecast
  10.2.3 Mexico Certolizumab Pegol Market Forecast
  10.2.4 Brazil Certolizumab Pegol Market Forecast
10.3 APAC Certolizumab Pegol Forecast by Region (2024-2029)
  10.3.1 China Certolizumab Pegol Market Forecast
  10.3.2 Japan Certolizumab Pegol Market Forecast
  10.3.3 Korea Certolizumab Pegol Market Forecast
  10.3.4 Southeast Asia Certolizumab Pegol Market Forecast
  10.3.5 India Certolizumab Pegol Market Forecast
  10.3.6 Australia Certolizumab Pegol Market Forecast
10.4 Europe Certolizumab Pegol Forecast by Country (2024-2029)
  10.4.1 Germany Certolizumab Pegol Market Forecast
  10.4.2 France Certolizumab Pegol Market Forecast
  10.4.3 UK Certolizumab Pegol Market Forecast
  10.4.4 Italy Certolizumab Pegol Market Forecast
  10.4.5 Russia Certolizumab Pegol Market Forecast
10.5 Middle East & Africa Certolizumab Pegol Forecast by Region (2024-2029)
  10.5.1 Egypt Certolizumab Pegol Market Forecast
  10.5.2 South Africa Certolizumab Pegol Market Forecast
  10.5.3 Israel Certolizumab Pegol Market Forecast
  10.5.4 Turkey Certolizumab Pegol Market Forecast
  10.5.5 GCC Countries Certolizumab Pegol Market Forecast
10.6 Global Certolizumab Pegol Forecast by Type (2024-2029)
10.7 Global Certolizumab Pegol Forecast by Application (2024-2029)

11 KEY PLAYERS ANALYSIS

11.1 UCB
  11.1.1 UCB Company Information
  11.1.2 UCB Certolizumab Pegol Product Offered
  11.1.3 UCB Certolizumab Pegol Revenue, Gross Margin and Market Share (2018-2023)
  11.1.4 UCB Main Business Overview
  11.1.5 UCB Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Certolizumab Pegol Market Size CAGR by Region (2018 VS 2022 VS 2029) & ($ Millions)
Table 2. Major Players of Single-dose vial
Table 3. Major Players of Single-dose prefilled syringe
Table 4. Certolizumab Pegol Market Size CAGR by Type (2018 VS 2022 VS 2029) & ($ Millions)
Table 5. Global Certolizumab Pegol Market Size by Type (2018-2023) & ($ Millions)
Table 6. Global Certolizumab Pegol Market Size Market Share by Type (2018-2023)
Table 7. Certolizumab Pegol Market Size CAGR by Application (2018 VS 2022 VS 2029) & ($ Millions)
Table 8. Global Certolizumab Pegol Market Size by Application (2018-2023) & ($ Millions)
Table 9. Global Certolizumab Pegol Market Size Market Share by Application (2018-2023)
Table 10. Global Certolizumab Pegol Revenue by Players (2018-2023) & ($ Millions)
Table 11. Global Certolizumab Pegol Revenue Market Share by Player (2018-2023)
Table 12. Certolizumab Pegol Key Players Head office and Products Offered
Table 13. Certolizumab Pegol Concentration Ratio (CR3, CR5 and CR10) & (2021-2023)
Table 14. New Products and Potential Entrants
Table 15. Mergers & Acquisitions, Expansion
Table 16. Global Certolizumab Pegol Market Size by Regions 2018-2023 & ($ Millions)
Table 17. Global Certolizumab Pegol Market Size Market Share by Regions (2018-2023)
Table 18. Global Certolizumab Pegol Revenue by Country/Region (2018-2023) & ($ millions)
Table 19. Global Certolizumab Pegol Revenue Market Share by Country/Region (2018-2023)
Table 20. Americas Certolizumab Pegol Market Size by Country (2018-2023) & ($ Millions)
Table 21. Americas Certolizumab Pegol Market Size Market Share by Country (2018-2023)
Table 22. Americas Certolizumab Pegol Market Size by Type (2018-2023) & ($ Millions)
Table 23. Americas Certolizumab Pegol Market Size Market Share by Type (2018-2023)
Table 24. Americas Certolizumab Pegol Market Size by Application (2018-2023) & ($ Millions)
Table 25. Americas Certolizumab Pegol Market Size Market Share by Application (2018-2023)
Table 26. APAC Certolizumab Pegol Market Size by Region (2018-2023) & ($ Millions)
Table 27. APAC Certolizumab Pegol Market Size Market Share by Region (2018-2023)
Table 28. APAC Certolizumab Pegol Market Size by Type (2018-2023) & ($ Millions)
Table 29. APAC Certolizumab Pegol Market Size Market Share by Type (2018-2023)
Table 30. APAC Certolizumab Pegol Market Size by Application (2018-2023) & ($ Millions)
Table 31. APAC Certolizumab Pegol Market Size Market Share by Application (2018-2023)
Table 32. Europe Certolizumab Pegol Market Size by Country (2018-2023) & ($ Millions)
Table 33. Europe Certolizumab Pegol Market Size Market Share by Country (2018-2023)
Table 34. Europe Certolizumab Pegol Market Size by Type (2018-2023) & ($ Millions)
Table 35. Europe Certolizumab Pegol Market Size Market Share by Type (2018-2023)
Table 36. Europe Certolizumab Pegol Market Size by Application (2018-2023) & ($ Millions)
Table 37. Europe Certolizumab Pegol Market Size Market Share by Application (2018-2023)
Table 38. Middle East & Africa Certolizumab Pegol Market Size by Region (2018-2023) & ($ Millions)
Table 39. Middle East & Africa Certolizumab Pegol Market Size Market Share by Region (2018-2023)
Table 40. Middle East & Africa Certolizumab Pegol Market Size by Type (2018-2023) & ($ Millions)
Table 41. Middle East & Africa Certolizumab Pegol Market Size Market Share by Type (2018-2023)
Table 42. Middle East & Africa Certolizumab Pegol Market Size by Application (2018-2023) & ($ Millions)
Table 43. Middle East & Africa Certolizumab Pegol Market Size Market Share by Application (2018-2023)
Table 44. Key Market Drivers & Growth Opportunities of Certolizumab Pegol
Table 45. Key Market Challenges & Risks of Certolizumab Pegol
Table 46. Key Industry Trends of Certolizumab Pegol
Table 47. Global Certolizumab Pegol Market Size Forecast by Regions (2024-2029) & ($ Millions)
Table 48. Global Certolizumab Pegol Market Size Market Share Forecast by Regions (2024-2029)
Table 49. Global Certolizumab Pegol Market Size Forecast by Type (2024-2029) & ($ Millions)
Table 50. Global Certolizumab Pegol Market Size Forecast by Application (2024-2029) & ($ Millions)
Table 51. UCB Details, Company Type, Certolizumab Pegol Area Served and Its Competitors
Table 52. UCB Certolizumab Pegol Product Offered
Table 53. UCB Certolizumab Pegol Revenue ($ million), Gross Margin and Market Share (2018-2023)
Table 54. UCB Main Business
Table 55. UCB Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Certolizumab Pegol Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Certolizumab Pegol Market Size Growth Rate 2018-2029 ($ Millions)
Figure 6. Certolizumab Pegol Sales by Geographic Region (2018, 2022 & 2029) & ($ millions)
Figure 7. Certolizumab Pegol Sales Market Share by Country/Region (2022)
Figure 8. Certolizumab Pegol Sales Market Share by Country/Region (2018, 2022 & 2029)
Figure 9. Global Certolizumab Pegol Market Size Market Share by Type in 2022
Figure 10. Certolizumab Pegol in Crohn’s disease
Figure 11. Global Certolizumab Pegol Market: Crohn’s disease (2018-2023) & ($ Millions)
Figure 12. Certolizumab Pegol in Active rheumatoid arthritis
Figure 13. Global Certolizumab Pegol Market: Active rheumatoid arthritis (2018-2023) & ($ Millions)
Figure 14. Certolizumab Pegol in Active psoriatic arthritis
Figure 15. Global Certolizumab Pegol Market: Active psoriatic arthritis (2018-2023) & ($ Millions)
Figure 16. Global Certolizumab Pegol Market Size Market Share by Application in 2022
Figure 17. Global Certolizumab Pegol Revenue Market Share by Player in 2022
Figure 18. Global Certolizumab Pegol Market Size Market Share by Regions (2018-2023)
Figure 19. Americas Certolizumab Pegol Market Size 2018-2023 ($ Millions)
Figure 20. APAC Certolizumab Pegol Market Size 2018-2023 ($ Millions)
Figure 21. Europe Certolizumab Pegol Market Size 2018-2023 ($ Millions)
Figure 22. Middle East & Africa Certolizumab Pegol Market Size 2018-2023 ($ Millions)
Figure 23. Americas Certolizumab Pegol Value Market Share by Country in 2022
Figure 24. United States Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 25. Canada Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 26. Mexico Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 27. Brazil Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 28. APAC Certolizumab Pegol Market Size Market Share by Region in 2022
Figure 29. APAC Certolizumab Pegol Market Size Market Share by Type in 2022
Figure 30. APAC Certolizumab Pegol Market Size Market Share by Application in 2022
Figure 31. China Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 32. Japan Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 33. Korea Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 34. Southeast Asia Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 35. India Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 36. Australia Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 37. Europe Certolizumab Pegol Market Size Market Share by Country in 2022
Figure 38. Europe Certolizumab Pegol Market Size Market Share by Type (2018-2023)
Figure 39. Europe Certolizumab Pegol Market Size Market Share by Application (2018-2023)
Figure 40. Germany Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 41. France Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 42. UK Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 43. Italy Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 44. Russia Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 45. Middle East & Africa Certolizumab Pegol Market Size Market Share by Region (2018-2023)
Figure 46. Middle East & Africa Certolizumab Pegol Market Size Market Share by Type (2018-2023)
Figure 47. Middle East & Africa Certolizumab Pegol Market Size Market Share by Application (2018-2023)
Figure 48. Egypt Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 49. South Africa Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 50. Israel Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 51. Turkey Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 52. GCC Country Certolizumab Pegol Market Size Growth 2018-2023 ($ Millions)
Figure 53. Americas Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 54. APAC Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 55. Europe Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 56. Middle East & Africa Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 57. United States Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 58. Canada Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 59. Mexico Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 60. Brazil Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 61. China Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 62. Japan Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 63. Korea Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 64. Southeast Asia Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 65. India Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 66. Australia Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 67. Germany Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 68. France Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 69. UK Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 70. Italy Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 71. Russia Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 72. Spain Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 73. Egypt Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 74. South Africa Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 75. Israel Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 76. Turkey Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 77. GCC Countries Certolizumab Pegol Market Size 2024-2029 ($ Millions)
Figure 78. Global Certolizumab Pegol Market Size Market Share Forecast by Type (2024-2029)
Figure 79. Global Certolizumab Pegol Market Size Market Share Forecast by Application (2024-2029)